Abstract
The use of double J ureteral stents can lead to several adverse effects, as urinary infection. Bacteria tend to colonize the stent surface, leading to the formation of bacterial biofilms. The presence of urease-producing bacteria increase the urine pH leading to the incrustation and blockage of the stent. On the other hand, these large crystalline masses function as niduses, allowing the attachment of even more bacteria and decreasing its exposure to antibiotics. The aim of this in vitro study was to assess the effect of phytate on the attachment of bacteria to the catheter surface under conditions that favor crystallization. Catheter sections were incubated in a synthetic urine medium (pH 6.5) in the presence or absence of Pseudomonas aeruginosa and phytate. Amount of calcium deposits was measured using an Arsenazo III colorimetric method and the number of attached bacteria to the stent was determined. Differences were assessed using an ANOVA with a Bonferroni post hoc test. The formation of calcium phosphate deposits (brushite and hydroxyapatite) and oxalate crystals (COM), as were as the amount of bacteria decreased when phytate was present. Thus, phytate successfully decreased bacterial adhesion by inhibiting the formation of crystalline deposits.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
A ureteral stent is an important medical device that can restore the normal flow of urine from the kidney to the bladder when there is an obstruction. These stents promote lumen dilatation and restore normal flow [1,2,3]. Although they typically resolve the problem of obstruction, the introduction of a stent can lead to adverse effects, such as an infection in the urinary system, and the stent can also become encrusted and obstructed over time [2].
The risk of a urinary tract infection (UTI) is linearly related to the duration of stent indwelling, and use of these stents for 30 days or more often leads to bacteriuria. Microorganisms tend to colonize the stent surface, leading to the formation of bacterial biofilms [4]. The presence of urease producing bacteria increase the urine pH due to their hydrolysis of urea into ammonia. When the urine pH is greater than 6.2, deposits of hydroxyapatite (HAP, Ca10[PO4]6[OH]2) and struvite (NH4MgPO4·6H2O) can form on the stent, leading to incrustation and blockage [5,6,7]. Incrustation may also occur without bacterial infection, because the stent can function as a heterogeneous nucleant for substances that are supersaturated in the urine [8,9,10].
The duration of catheter indwelling increases the risk of stent encrustation and blockage [11,12,13], and can lead to a rigid catheter with reduced tensile strength [14]. This increases the risk of ureter trauma or injury during stent removal, and the leakage of the urine within the body.
The relationship between biofilm formation and catheter encrustation is unclear, although some studies of urethral and ureteral stents have shown a clear feedback during the process. On the one hand, bacterial adhesion and biofilm formation on the catheter surface can promote crystal deposition and encrustation [4, 15, 16]; on the other hand, encrustation may provide niduses for the colonization of bacteria and the formation of a bacterial crystal biofilm [17,18,19].
Previous research reported that consumption of myo-inositol hexaphosphate (InsP6, phytate) can inhibit the formation of renal calculi [20] and reduce the encrustation of ureteral stents [10]. The aim of the present in vitro study is to assess the effect of phytate on the attachment of bacteria and the formation of niduses on the catheter surface when conditions are favorable for the formation of calcium phosphate crystals.
Materials and methods
Solutions and batch system
Synthetic urine was prepared by a making fresh mixture of equal volumes of two solutions, with solution A containing CaCl2 and solution B containing Na2C2O4 (Table 1). The pH of each solution was adjusted to 6.5, a condition that promotes crystallization of calcium phosphate and calcium oxalate monohydrate (COM). Glucose and albumin (Sigma-Aldrich, St. Louis, USA) were added to solution B. Glucose was the carbon source for bacterial growth, and albumin was a mimic of the proteinaceous debris present in infected urine. Different amounts of phytic acid sodium salt (P8810, Sigma-Aldrich, St. Louis, USA) were also added to solution B. The synthetic urine components were obtained from PanReac (Barcelona, Spain).
Experiments were performed in sterile 50 mL Falcon tubes. Each tube contained a hydro-coated silicon catheter section that was 1.5 cm long (BCHG64, Coloplast, Humlebaek, Denmark) and attached to a needle for support (Fig. 1). Each Falcon tube was filled with 20 mL of solution A and 20 mL of solution B, and maintained for 24 h at 37 °C.
Calcium analysis
After 24 h, each catheter deposit was dissolved with 0.5 M HCl, and resulting solution was adjusted to pH 3.0 for analysis. Calcium was determined using an Arsenazo III colorimetric method [21]. All measurements were performed in triplicate.
Bacterial attachment assays
Bacterial attachment assays were performed using P. aeruginosa reference strain PAO1, which was originally isolated from an infected wound [22]. For these assays, the strain was grown 18 h at 37 °C in artificial urine without phytic acid.
Catheter sections of 1.5 cm were placed into sterile tubes containing 40 mL of artificial urine (20 mL solution A + 20 mL solution B) without or with phytate (0, 1.2, or 2.4 μM). Tubes were inoculated with bacterial cells of P. aeruginosa PAO1 that were grown overnight in synthetic urine without phytate to a final concentration of 108 viable bacterial cells/mL and incubated 24 h at 37 °C without shaking. After this incubation, catheter sections were transferred to new sterile microfuge tubes using sterile forceps and rinsed with 4 mL of sterile phosphate buffered saline (PBS) to remove unattached bacteria. Next, catheter sections were placed in new microfuge tubes containing 1 mL of PBS that were centrifuged at 13,000×g for 30 min to harvest the bacterial cells. Finally, the catheter sections were discarded, and the pellet of bacteria detached from the catheters was resuspended in 1 mL of PBS. Bacterial cells were quantified by plating appropriate dilutions of the bacterial suspension on Luria Bertani agar plates. Results were expressed as Colony Forming Units (CFU) per mL of PBS. A negative control, consisting in catheter without bacteria, was processed in parallel.
Scanning electron microscopy
The morphological and structural characteristics of the deposits that formed on the surface of the stent in absence and presence of InsP6 and P. aeruginosa were examined using scanning electron microscopy (SEM, Hitachi S-3400N) coupled with RX energy dispersive microanalysis (Bruker AXS XFlash Detector 4010). Stents were washed with Mili-Q water to remove artificial urine residues to avoid the formation of NaCl and KCl crystals. After washing them, they were left to dry for 1 day at room temperature. Afterwards, stents were stuck on a sample holder with adhesive tape to avoid their displacement and observed with SEM without any other preparation.
Statistics
Normality graphs were used to assess data distributions. Data were presented as means and standard errors of the means (SEMs). The amounts of calcium and attached bacteria in the different groups were compared using an ANOVA with a Bonferroni post hoc test. A two-tailed p value less than 0.05 was considered statistically significant. Statistical analyses were performed using SPSS version 25.0 (SPSS Inc., Chicago, IL, USA).
Results
Effect of phytate on formation of calcium crystals
We first determined the amount of calcium deposited on the catheters after 24 h of incubation with different concentrations of phytate (Fig. 2A). The results indicated that the formation of calcium phosphate deposits (brushite and hydroxyapatite) and oxalate crystals (COM) decreased when phytate was added. Scanning electron microscopy of catheter sections confirmed that phytate inhibited the formation of brushite and COM crystals. The presence of phytate led to only a thin layer of organic matter on the catheter surface (Fig. 3C, D, G and H).
Effect of phytate on attachment of bacteria
We also measured the levels of bacteria that were attached to the catheters after 24 h of incubation with different concentrations of phytate (Fig. 2B). Similar to the crystallization experiments, the amount of bacteria decreased by more than tenfold when phytate was added. Scanning electron microscopy of the catheter sections indicated that brushite, HAP, and COM crystals formed when the solution contained no phytate (Fig. 3E, F). However, only a thin layer of organic matter was detected when phytate was present in the solution (Fig. 3G, H). To confirm that the layer observed was organic matter and not only the hydro coating of the catheter, a picture of a catheter section before use was taken (Fig. 4A).
Discussion
The formation of biofilm on a ureteral stent is a multistep process that is not yet completely understood [14]. Some researchers found that UTIs lead to the development of catheter biofilms and raise the urinary pH above 6.2. This elevated pH favors the crystallization of struvite and HAP. This crystalline layer then provides niduses for the establishment of even more bacteria.
However, a crystalline layer can also form on the catheter surface in the absence of infection [9, 10], depending on urine composition and pH. This is consistent with the observation of other researchers who found that the first step in the development of bacterial biofilms was the formation of a crystalline layer [18, 19]. This initial calcium-based crystalline layer allows bacterial attachment and biofilm formation, and these bacteria can increase the pH to above 6.2. This elevated pH then favors the formation of additional deposits, such as struvite. These large crystalline masses function as niduses, allowing the attachment of even more bacteria [17]. Thus, there appears to be a positive feedback loop of stent crystallization and bacterial colonization.
Although the details of stent crystallization and bacterial colonization are not completely elucidated, it seems important to prevent the formation of crystalline deposits to prevent bacterial proliferation, whichever process occurs first. Because a high urine pH favors the formation of calcium deposits, we performed our in vitro experiments at a pH of 6.5 to promote the formation of calcium-based crystals, such as calcium phosphate (brushite and HAP) and calcium oxalate. Notably, phytate is well-known to inhibit the formation of these types of deposits, and we, therefore, evaluated the effect of phytate on crystallization and bacterial attachment.
The results showed that phytate was effective in preventing the formation of a calcium-based crystalline layer in the absence of bacteria (Fig. 3A–D) and in the presence of P. aeruginosa (Fig. 3E–H). Thus, brushite, HAP and calcium oxalate deposits were minimal on stents that were incubated with 1.2 or 2.4 μM phytate. This was supported by our measurements of the level of calcium concentration (Fig. 2A), which indicated much lower levels when the stents were incubated with phytate. Moreover, the layer of organic matter that formed in the absence of bacteria (Fig. 3C, D) and in presence of bacteria (Fig. 3G, H) had a similar morphology.
A more than tenfold decrease in the number of bacteria on the catheter surface when the artificial urine included 1.2 or 2.4 μM phytate (Fig. 2B) was also observed. This finding, together with our results on crystal formation, indicated that phytate reduced the number of bacteria attached on a stent surface by preventing the formation of the crystalline layer. It is important to prevent niduses and crystalline mass formation, because this can occlude the lumen of the ureter and generate significant clinical complications, as well as persistent urinary tract infections.
Finally, crystal formation and bacterial adherence on the stent were each similar at phytate concentrations of 1.2 and 2.4 µM. At both concentrations, very few crystals formed, and the few bacteria that were present adhered directly to the surface or the interior lumen of the catheter. This confirms that bacteria adhere to a catheter surface even in the absence of a crystalline layer, forming an initial biofilm layer with the organic matter. Therefore, from the results of this research it was conclude that phytate successfully decreased the number of bacteria that adhered to a catheter surface by inhibiting the formation of a calcium-based crystalline layer, which functions as locus for bacterial colonization and growth.
Early prevention of the formation of calcium-based deposits could be a key to preventing subsequent persistent urinary system infections and their many adverse consequences. In addition, our results indicated that the large crystals on a catheter can serve as a locus for bacterial growth, because there are far fewer bacteria on the catheter surface when these crystals do not develop. It is likely that the absence of catheter deposits in vivo may also increase exposure of bacteria on the catheter surface to antibiotics.
References
Mosayyebi A, Vijayakumar A, Yue QY et al (2017) Engineering solutions to ureteral stents: material, coating and design. Cent Eur J Urol 70:270–274. https://doi.org/10.5173/ceju.2017.1520
Beysens M, Tailly TO (2018) Ureteral stents in urolithiasis. Asian J Urol 5:274–286. https://doi.org/10.1016/j.ajur.2018.07.002
Dyer RB, Chen MY, Zagoria RJ et al (2002) Complications of ureteral stent placement. Radiographics 22:1005–1022. https://doi.org/10.1148/radiographics.22.5.g02se081005
Stickler DJ (2008) Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol 5:598–608. https://doi.org/10.1038/ncpuro1231
Hedelin H, Eddeland A, Larsson L et al (1984) The composition of catheter encrustations, including the effects of allopurinol treatment. Br J Urol 56:250–254. https://doi.org/10.1111/j.1464-410X.1984.tb05382.x
Cox AJ, Hukins DWL (1989) Morphology of mineral deposits on encrusted urinary catheters investigated by scanning electron microscopy. J Urol 142:1347–1350. https://doi.org/10.1016/S0022-5347(17)39095-X
Tian S, Hu N, Lou J et al (2020) Characteristics of COVID-19 infection in Beijing. J Infect. https://doi.org/10.1016/j.jinf.2020.02.018
Wollin TA, Tieszer C, Riddell JV et al (1998) Bacterial biofilm formation, encrustation, and antibiotic adsorption to ureteral stents indwelling in humans. J Endourol 12:101–111. https://doi.org/10.1089/end.1998.12.101
Bouzidi H, Traxer O, Doré B et al (2008) Caractéristiques des incrustations des endoprothèses urétérales chez les patients lithiasiques. Prog en Urol 18:230–237. https://doi.org/10.1016/j.purol.2008.02.004
Torrecilla C, Fernández-Concha J, Cansino JR et al (2020) Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial. BMC Urol 20:65. https://doi.org/10.1186/s12894-020-00633-2
Acosta-Miranda AM, Milner J, Turk TMT (2009) The FECal double-J: a simplified approach in the management of encrusted and retained ureteral stents. J Endourol 23:409–415. https://doi.org/10.1089/end.2008.0214
El-Faqih SR, Shamsuddin AB, Chakrabarti A, Atassi R, Kardar AH, Osman MKHI (1991) Polyurethane internal ureteral stents in treatment of stone patients: morbidity related to indwelling times. J Urol 146:1487–1491. https://doi.org/10.1016/s0022-5347(17)38146-6
Kawahara T, Ito H, Terao H et al (2012) Ureteral stent encrustation, incrustation, and coloring: morbidity related to indwelling times. J Endourol 26:178–182. https://doi.org/10.1089/end.2011.0385
Tomer N, Garden E, Small A, Palese M (2021) Ureteral stent encrustation: epidemiology, pathophysiology, management and current technology. J Urol 205:68–77. https://doi.org/10.1097/JU.0000000000001343
Wilks SA, Fader MJ, Keevil CW (2015) Novel insights into the proteus mirabilis crystalline biofilm using real-time imaging. PLoS ONE. https://doi.org/10.1371/journal.pone.0141711
Zumstein V, Betschart P, Albrich WC et al (2017) Biofilm formation on ureteral stents—incidence, clinical impact and prevention. Swiss Med Wkly 147:w14408. https://doi.org/10.4414/smw.2017.14408
Tieszer C, Reid G, Denstedt J (1998) XPS and SEM detection of surface changes on 64 ureteral stents after human usage. J Biomed Mater Res 43:321–330. https://doi.org/10.1002/(SICI)1097-4636(199823)43:3%3c321::AID-JBM14%3e3.0.CO;2-I
Stickler DJ, Morgan SD (2008) Observations on the development of the crystalline bacterial biofilms that encrust and block Foley catheters. J Hosp Infect 69:350–360. https://doi.org/10.1016/j.jhin.2008.04.031
Winters C, Stickler DJ, Howe NS et al (1995) Some observations on the structure of encrusting biofilms of Proteus mirabilis on urethral catheters. Cells Mater 5:245–253
Grases F, Isern B, Sanchis P et al (2007) Phytate acts as an inhibitor in formation of renal calculi. Front Biosci 12:2580–2587
Michaylova V, Ilkova P (1971) Photometric determination of micro amounts of calcium with arsenazo III. Anal Chim Acta 53:194–198. https://doi.org/10.1016/S0003-2670(01)80088-X
Holloway BW (1955) Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 13:572–581. https://doi.org/10.1099/00221287-13-3-572
Acknowledgements
Financial support from Agencia Estatal de Investigación (Spain) (PID2019-104331RB-I00/AEI/10.13039/501100011033) is acknowledged. P. Calvó is grateful to the Conselleria d'Educació, Universitat i Recerca of the Government of the Balearic Islands for the fellowship FPI_003_2020. M. Mateu is the recipient of a FPI fellowship from Comunitat Autònoma de les Illes Balears (CAIB).
Funding
Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.
Author information
Authors and Affiliations
Contributions
PC: formal analysis, investigation, methodology, writing—original draft preparation. MM-B: formal analysis, investigation. AC: conceptualization, methodology, project administration, supervision, writing—review and editing. SA: project administration, resources, supervision. FG: conceptualization, project administration, supervision, writing—review and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Animal studies
Not applicable.
Approval of the research protocol by an Institutional Reviewer Board
Not applicable.
Informed consent
Not applicable.
Registry and the registration no. of the study/trial
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Calvó, P., Mateu-Borras, M., Costa-Bauza, A. et al. Effect of phytate on crystallization on ureteral stents and bacterial attachment: an in vitro study. Urolithiasis 50, 737–742 (2022). https://doi.org/10.1007/s00240-022-01350-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-022-01350-1